Yahoo Web Search

Search results

    • Q1 2024 Neurocrine Biosciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 hours ago

      After 7 years, INGREZZA is the #1 prescribed VMAT2 inhibitor for the treatment of tardive dyskinesia or TD. INGREZZA is the only treatment proven to reduce TD symptoms with ...